Taken together, future evaluation of the associations of CSF VAMP-2 and SNAP-25 with in vivo neural correlates (e.g. hippocampal atrophy) of declining episodic memory and other cognitive functions in AD patients as measured with structural MRI [54], could provide valuable information. Here, VAMP2 is linked to Alzheimer disease.